“Cardiac glycosides”—quo vaditis?—past, present, and future?
Naunyn-Schmiedeberg's Archives of Pharmacology · 2024
DOI: 10.1007/s00210-024-03285-3 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2024. Verfasst von Julia Fender und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pharmacology and Toxicology, University of Würzburg, Versbacher Straße 9, 97078, Würzburg, Germany. Hauptthemen laut MEDLINE: Cardiac Glycosides. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bundesministerium für Bildung und Forschung, Deutsche Forschungsgemeinschaft, Julius-Maximilians-Universität Würzburg.
Abstract (Originalsprache)
Up to date, digitalis glycosides, also known as “cardiac glycosides”, are inhibitors of the Na + /K + -ATPase. They have a long-standing history as drugs used in patients suffering from heart failure and atrial fibrillation despite their well-known narrow therapeutic range and the intensive discussions on their raison d’être for these indications. This article will review the history and key findings in basic and clinical research as well as potentially overseen pros and cons of these drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Pharmacology and Toxicology, University of Würzburg, Versbacher Straße 9, 97078, Würzburg, Germany.
- Institute of Experimental Cardiovascular Medicine, Faculty of Medicine, University of Freiburg, Elsässer Straße 2Q, 79110, Freiburg, Germany.
- Interdisciplinary Bank of Biological Materials and Data Würzburg (ibdw), University Hospital Würzburg, Straubmühlweg 2a, 97078, Würzburg, Germany.
- Institute of Pharmacology and Toxicology, University of Würzburg, Versbacher Straße 9, 97078, Würzburg, Germany. kristina.lorenz@uni-wuerzburg.de.
- Leibniz-Institut für Analytische Wissenschaften-ISAS e.V., Bunsen-Kirchhoff-Straße 11, 44139, Dortmund, Germany. kristina.lorenz@uni-wuerzburg.de.
Förderung
- Bundesministerium für Bildung und Forschung
- Deutsche Forschungsgemeinschaft
- Julius-Maximilians-Universität Würzburg
Zitieren
APA
Fender, J., Klöcker, J., Boivin-Jahns, V., Ravens, U., Jahns, R., & Lorenz, K. (2024). “Cardiac glycosides”—quo vaditis?—past, present, and future?. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-024-03285-3
Vancouver
Fender J, Klöcker J, Boivin-Jahns V, Ravens U, Jahns R, Lorenz K. “Cardiac glycosides”—quo vaditis?—past, present, and future?. Naunyn-Schmiedeberg's Archives of Pharmacology. 2024. doi:10.1007/s00210-024-03285-3
BibTeX
@article{Fender2024,
author = {Fender, Julia and Klöcker, Johanna and Boivin-Jahns, Valérie and Ravens, Ursula and Jahns, Roland and Lorenz, Kristina},
title = {“Cardiac glycosides”—quo vaditis?—past, present, and future?},
journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
year = {2024},
doi = {10.1007/s00210-024-03285-3}
}
EUVIMED